MiMedx Group, Inc MDXG

4.67 (0.04) (0.85%) as of 25 Sep
Market cap
$686.5M
P/E
117×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
418.63 348.88 321.48 267.84 242.02 248.23 299.26 359.11 321.14 221.71
Revenue Growth
19.99% 8.52% 20.03% 10.67% (2.50%) (17.05%) (16.67%) 11.82% 44.85% 18.38%
Cost of Revenue
73.01 60.07 54.63 48.32 39.63 39.33 43.08 36.39 35.22 30.94
Gross Profit
345.62 288.81 266.84 219.53 202.39 208.90 256.17 322.73 285.92 190.77
R&D Expenses
15.10 12.34 12.67 12.70 9.93 11.72 11.14 15.77 17.90 14.34
SG&A Expenses
266.19 225.09 211.12 208.67 194.85 181.02 198.21 258.53 220.12 173.41
Operating Income
63.89 58.87 37.12 (14.73) (7.05) (45.40) (21.16) (3.92) 46.22 0.88
Non-operating Income/Expense
2.38 (1.57) (6.48) (5.02) (5.00) (16.14) (4.42) 0.53 (1.13) (0.34)
Non-operating Interest Expenses
— 1.01 6.46 5.02 4.98 7.94 4.71 0.53 — —
EBT
66.26 57.29 30.63 (19.75) (12.05) (61.54) (25.58) (3.40) 45.09 0.55
Income Tax Provision
17.68 15.30 (36.81) 0.21 0.25 (12.26) 0.00 26.58 (19.64) 0.16
Income after Tax
48.58 42.00 67.44 (19.95) (12.30) (49.28) (25.58) (29.98) 64.73 0.39
Dividends (Preferred)
— — 11.64 6.58 6.14 34.04 — — — 0.00
Net Income Common
48.58 42.42 58.23 (36.78) (16.42) (83.33) (25.58) (29.98) 64.73 0.39
EPS (Basic)
0.33 0.29 0.40 (0.33) (0.15) (0.77) (0.23) (0.28) 0.58 0.00
EPS (Diluted)
0.32 0.28 0.37 (0.33) (0.15) (0.77) (0.24) (0.28) 0.56 0.00
Shares (Basic, Weighted)
147.79 146.98 116.50 112.91 110.35 108.26 106.95 105.60 106.12 105.93
Shares (Diluted, Weighted)
149.72 149.05 145.96 112.91 110.35 108.26 106.95 105.60 116.11 112.65
Gross Margin
82.56% 82.78% 83.01% 81.96% 83.63% 84.16% 85.60% 89.87% 89.03% 86.05%
EBIT Margin
15.26% 16.87% 11.55% (5.50%) (2.91%) (18.29%) (7.07%) (1.09%) 14.39% 0.40%
EBT margin
15.83% 16.42% 9.53% (7.37%) (4.98%) (24.79%) (8.55%) (0.95%) 14.04% 0.25%
Net Profit Margin
11.60% 12.16% 18.11% (13.73%) (6.79%) (33.57%) (8.55%) (8.35%) 20.16% 0.18%
Free Cash Flow Margin
17.43% 18.49% 7.71% (7.25%) (2.25%) (14.03%) (13.91%) 7.18% 17.92% 7.58%
EBITDA
78.77 64.91 40.54 (10.68) (0.81) (36.27) (12.14) 2.94 52.36 7.99
EBIT
63.89 58.87 37.12 (14.73) (7.05) (45.40) (21.16) (3.92) 46.22 0.88
Income from Continuous Operations
48.58 42.00 67.44 (19.95) (12.30) (49.28) (25.58) (29.98) 64.73 0.39
Income from Discontinued Operations
— 0.42 (9.21) (10.24) 2.02 — — — — —
Consolidated Net Income/Loss
48.58 42.42 58.23 (30.20) (10.28) (49.28) (25.58) (29.98) 64.73 0.39
EPS (Basic, from Continuous Ops)
0.33 0.29 0.48 (0.24) (0.11) (0.46) (0.24) (0.28) 0.61 0.00
EPS (Basic, from Discontinued Ops)
— 0.00 (0.08) (0.09) 0.02 — — — — —
EPS (Basic, Consolidated)
0.33 0.29 0.50 (0.27) (0.09) (0.46) (0.24) (0.28) 0.61 0.00
EPS (Diluted, from Cont. Ops)
0.32 0.28 0.43 (0.24) (0.11) (0.46) (0.24) (0.28) 0.56 0.00
EPS (Diluted, from Disc. Ops)
— 0.00 0.00 0.00 0.00 — — — — —
Shares (Diluted, Average)
149.73 149.05 145.96 112.91 110.35 108.26 — 105.60 — 112.44
EPS (Diluted, Consolidated)
0.32 0.28 0.40 (0.27) (0.09) (0.46) (0.24) (0.28) 0.56 0.00
EBITDA Margin
18.82% 18.60% 12.61% (3.99%) (0.34%) (14.61%) (4.06%) 0.82% 16.30% 3.60%
Operating Cash Flow Margin
17.68% 18.97% 8.33% (6.68%) (0.82%) (12.19%) (13.17%) 9.97% 19.60% 10.76%

Fold the line items

In millions of $ except per-share values · columns are period end dates